SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: axial who wrote (8465)1/21/2002 9:38:29 AM
From: Cal Gary  Read Replies (1) of 14101
 
Hi Jim and threadsters

I follow PBP because of its partnering with Biovail. It has a wound healer topical cream at the pre-IND submission to FDA for phase III human clinicals.

Biovail has paid good upfront money (with more milestone payments to come) to lockup marketing rights.

This should give us an example of how to value Oxoferin.

Check them out at:
procyonbiopharma.com

News release for PBP of course is also at this site.

DMX: will 2Q be on time?

[EDIT]
PS US Markets are closed today, Martin Luther King day.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News